Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Vivus launches new device for erectile dysfunction in the U.S.

July 29, 1997

Papaverine/phentolamine compared to PGE1 for erectile dysfunction

July 29, 1997

Unigene Laboratories and Parke-Davis to develop oral calcitonin for osteoporosis

July 29, 1997

Statins protect against stroke and CVD

July 29, 1997

Potential alternative for long-term treatment of obesity

July 28, 1997

BioTime's Hextend enters European clinical trials; licensed to Abbott

July 28, 1997

Forbes Medi-Tech submits patent, reports on clinical trials

July 28, 1997

New approaches to the pharmacological treatment of obesity

July 25, 1997

Infant nutrition as a way of preventing IDDM

July 25, 1997

Diabetes classification not as clear-cut as previously thought

July 25, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...